Deceleration of glycometabolism impedes IgG-producing B-cell-mediated tumor elimination by targeting SATB1

Immunology
Jiajing LiuYiwei Chu

Abstract

B lymphocytes, known as antibody producers, mediate tumor cell destruction in the manner of antibody-dependent cell-mediated cytotoxicity; however, their anti-tumor function seems to be weakened during tumorigenesis, while the underlying mechanisms remain unclear. In this study, we found that IgG mediated anti-tumor effects, but IgG-producing B cells decreased in various tumors. Considering the underlying mechanism, glycometabolism was noteworthy. We found that tumor-infiltrating B cells were glucose-starved and accompanied by a deceleration of glycometabolism. Both inhibition of glycometabolism and deprivation of glucose through tumor cells, or glucose-free treatment, reduced the differentiation of B cells into IgG-producing cells. In this process, special AT-rich sequence-binding protein-1 (SATB1) was significantly silenced in B cells. Down-regulating SATB1 by inhibiting glycometabolism or RNA interference reduced the binding of signal transducer and activator of transcription 6 (STAT6) to the promoter of germline Cγ gene, subsequently resulting in fewer B cells producing IgG. Our findings provide the first evidence that glycometabolic inhibition by tumorigenesis suppresses differentiation of B cells into IgG-producing cells,...Continue Reading

References

Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·Z SteplewskiH Koprowski
Apr 1, 1994·Cancer Immunology, Immunotherapy : CII·C J PuntE M Hersh
Jul 3, 2008·Cancer Research·Marcus SchmidtMathias Gehrmann
Aug 30, 2008·Blood·Tucker W LeBien, Thomas F Tedder
Jun 25, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Erica L CarpenterRobert H Vonderheide
May 21, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marian L TurnerPhilip D Hodgkin
Oct 22, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Brad H Nelson
Apr 8, 2011·Nature Reviews. Immunology·Diane Mathis, Steven E Shoelson
Oct 12, 2011·Annual Review of Cell and Developmental Biology·Sophia Y Lunt, Matthew G Vander Heiden
Dec 5, 2012·Trends in Immunology·Frances BalkwillMelania Capasso
Feb 15, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katarzyna WejkszaArya Biragyn
Feb 16, 2013·Nature Reviews. Immunology·Inessa Schwab, Falk Nimmerjahn
Apr 23, 2013·Immunity·Erika L Pearce, Edward J Pearce
Oct 25, 2013·Nature Reviews. Cancer·Eran ElinavRichard A Flavell
Feb 6, 2014·Immunology Letters·Rick KapurGestur Vidarsson
Jun 6, 2014·Journal of Immunology Research·Glauben LandskronMarcela A Hermoso
Apr 30, 2015·Nature·Laurence Zitvogel, Guido Kroemer
Dec 31, 2015·Cancer Discovery·Yuliya Pylayeva-GuptaDafna Bar-Sagi
Feb 26, 2016·Frontiers in Immunology·Susana Romero-GarciaFrancisco Javier Sánchez-García
Apr 7, 2016·Journal of Ovarian Research·Sebastian LundgrenKarin Jirström
Apr 12, 2016·Biochemical and Biophysical Research Communications·Enyu HuangYiwei Chu
Sep 27, 2016·Cell·Lenette L LuGalit Alter
Nov 14, 2016·Cellular and Molecular Life Sciences : CMLS·Jun Kunisawa
Jan 19, 2017·Immunity·Tom L StephenJose R Conejo-Garcia
Mar 11, 2017·Targeted Oncology·Nicole J FlynnJennifer Sims-Mourtada
Mar 24, 2017·Gut Microbes·Myunghoo Kim, Chang H Kim
Apr 28, 2017·Frontiers in Oncology·Seema GuptaBilikere S Dwarakanath
May 17, 2017·Oncoimmunology·Giulia ChiaruttiniSophia N Karagiannis
Jun 20, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Masataka TorigoeYoshiya Tanaka
Jun 20, 2017·Cellular & Molecular Immunology·Anushruti SarvariaAurore Saudemont
Sep 1, 2017·Clinical Microbiology Reviews·Jiro Sakai, Mustafa Akkoyunlu
Oct 13, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zhou LuYiwei Chu
Dec 5, 2017·Cellular & Molecular Immunology·Chien-Hui Chien, Bor-Luen Chiang
Jul 17, 2018·Cell·Yoku Hayakawa, Timothy C Wang

❮ Previous
Next ❯

Citations

May 28, 2019·Cancer Cell International·Xiaodan LuoLian Liu
Feb 26, 2021·Frontiers in Oncology·Jun YangHushan Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.